Prime Movers

Learn about the top trends and technologies in mineral extraction. Hosted by former Prime Movers Lab Partner Gaetano Crupi and Research fellow Mitch Juneau. This conversation was originally recorded on Sep 28, 2022.

Panelists include:

• Aaron Wilson, Chemical Separations Group Lead and Research Chemist at the Idaho National Laboratory
• Nicholas Myers, CEO & Co-Founder of Phoenix Tailings
• Jeff Urban, Lead of LBL Thermoelectric Program, MSD Lead on Water-Energy Initiative at Berkeley Lab

Learn about President Joe Biden’s FY2024 budget request for science and technology programs and which ones are the most likely to pass the Republican-controlled House. Hosted by Prime Movers Lab Partners Gavin Mathis and Pritha Ghosh.

Panelists include:

• Marissa Serafino, Associate - Holland & Knight
• Matt Hourihan, Associate Director of R&D and Advanced Industry - Federation of American Scientists
• Mike O'Neill, Associate - K&L Gates

What industries are being automated first? Why now? What developments make this the right moment to build robots? Just how automated is the world today? And what about humanoids?

Panelists:

Rodney Brooks, CTO and Founder at Robust.AI, Founder at Rethink Robotics, iRobot, Lucid Inc, Panasonic Professor of Robotics at MIT, and former director of the MIT Computer Science and Artificial Intelligence Laboratory

Joyce Sidopoulos, Cofounder and COO at MassRobotics, Co-founder at Robots.Jobs

David Bell, Cofounder and CEO at Remedy Robotics

Advances in scientific breakthroughs, such as single-cell technologies, have led to the increased ability to detect diseases. Accurate and early detection of disease can lead to the enhanced effectiveness of treatments and reduce burdens on the healthcare system. Join Partner Justin Briggs and Research Fellow Ted Ling Hu as they do a deep dive into the emerging trends in the field of diagnostics with our panel of experts.

• Swamy Vijayan, CEO & Co-founder of Zafrens — Vijayan is a serial entrepreneur who founded Omniome and Plexium. Swamy’s current venture, Zafrens, unlocks cellular analysis through ultra-high throughput single-cell screening. The technique provides deep insights that unlock unprecedented diagnostic and therapeutic value.

• Daniel Georgiev, CEO and Co-founder of Sampling Human — Daniel is the co-founder and CEO of Sampling Human, which creates new technologies that harness the processing power of biology to measure single cells at scale. He is also a tenured professor at the Faculty of Applied Sciences at the University of West Bohemia.

• John McDevitt, Chief Scientist & Founder of OraLiva — McDevitt is the Scientific Founder of Oraliva, Inc. and is a pioneer in the development of programmable bio-nano-chip technologies. He is a Full Professor in the Department of Biomaterials at NYU Dentistry and a member of NYU’s Bioengineering Institute. He also holds a joint appointment at the Tandon School of Engineering (Department of Chemical and Biomolecular Engineering).